1. Therapeutic response at days 10-13 was greater in the gepotidacin group compared to the nitrofurantoin group across both trials. 2. Gepotidacin use was associated with diarrhea as the most common adverse event and no significant fatalities were reported. Evidence Rating Level: 1 (Excellent) Study Rundown: Urinary tract infections (UTIs) affect a large portion of